(Q35565781)

8 August 2017

title

Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. jean.de.serres@aventis.com (English)

1 reference

8 August 2017

main subject

hereditary angioedema

1 reference

Jean De Serres

1

1 reference

8 August 2017

Albrecht Gröner

series ordinal

2

1 reference

8 August 2017

Jürgen Lindner

series ordinal

3

1 reference

8 August 2017

publication date

1 December 2003

1 reference

Transfusion and Apheresis Science

8 August 2017

published in

1 reference

8 August 2017

volume

29

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

247-254

1 reference

Type I hereditary angio-oedema. Variability of clinical presentation and course within two large kindreds.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Hereditary angioedema: a broad review for clinicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

C1-inhibitor deficiency and angioedema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

[Hereditary angioneurotic edema. Clinical picture, diagnosis, patient management and drug therapy]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Clinical management of hereditary angio-oedema in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

[The use of a C1-inhibior concentrate for short-term preoperative prophylaxis in two patients with hereditary angioedema]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Successful off-pump coronary artery bypass graft surgery in a patient with hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Colorectal intussusception: an unusual gastrointestinal complication of hereditary angioedema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Successful use of C1 esterase inhibitor protein in a patient with hereditary angioneurotic edema requiring coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Hereditary angioedema: an appraisal of 104 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

C1 INH concentrate in the therapy of hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Hereditary angio-oedema: treatment with C1 esterase inhibitor concentrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Treatment of hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Can C1 esterase inhibitor concentrate be a cause of the exacerbation of hereditary angioneurotic oedema?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

C1-esterase inhibitor transfusions in patients with hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Hepatitis C and pasteurized C1-inhibitor concentrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2003.08.006

10.1016/J.TRANSCI.2003.08.006

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference